McAleer & Rushe secures tenants for Kildress House office scheme
Proximo Spirits and Muzinich to pay over €55 per sq ft for fourth and fifth floors
Dublin 2 Georgian office and mews guiding at €2.3m
94 Lower Baggot Street for sale with vacant possession following departure of Wyse
MSD announces 240 new jobs with expansion at Dunboyne
Pharma giant to build research centre next to biologic medicines plant acquired this year
AstraZeneca and Gilead explore possibility of merger
Shares dip as it emerges there are no active talks on what would be politically sensitive deal
Takeda overhauls Shire’s Irish structure to ease dividend payments
Pharma giant moves to make it easier for profits to be repatriated from State to Japan
Foreign direct investment to State rebounds on Takeda deal for Shire
Global FDI flows flat last year at $1.39 trillion but moderate growth forecast this year
Big spending election promises and Dublin hotel room taxes
Seen and heard: Reports of multimillion euro data centres for Drogheda and Arklow
Outbound Irish M&A hits three-year high despite decline in deals
Inbound M&A, involving an Irish target and a foreign buyer, totalled $8.9bn
Botox-maker left with bitter taste after Donohoe tax crackdown
AbbVie’s purchase of Allergan is collateral damage as Minister targets Green Reit deal
Grade A office space at 6 Pembroke Row to let at competitive €55 per sq ft
Building offers occupier core location in Dublin’s central business district
Outlook positive for 2019 despite uncertainties
Private equity and technology expected to contribute to growth in Ireland
Paschal meets Apple bigwigs as AIB seeks help-to-buy scheme extension
Seen and heard: PwC to review children’s hospital costs, ESB may offload Dublin depot
Hard Brexit would cut Irish corporate deals by 40% – report
No deal with EU would also reduce appetite for mergers and acquisitions
Irish giant Shire gets go-ahead to market new treatment
Takhzyro is a preventive treatment for the genetic condition hereditary angioedema
Irish giant Shire welcomes ‘important’ clinical trial result
Experimental drug led to ‘significantly fewer’ attacks of life-threatening genetic condition
Takeda to close $62bn deal for Irish company Shire in January
Date set for extraordinary general meeting to secure shareholder backing for acquisition
Takeda considering sale of Shire eye care business once acquisition completes
Japanese pharmaceutical company looking to cut debt raised to fund the deal
Shire sells oncology franchise to Servier for $2.4bn
Sale proceeds are expected to enable pharma giant to further reduce its leverage
Stocks rally after Fed chair’s key speech while oil prices surge
Kingspan was standout performer of the day, rising 9.5 per cent following strong H1 results
Planning permission denied for Magee Barracks redevelopment
Site in Kildare town made more than four times its guide price when sold in early 2017
Letterkenny-based tech start-up snapped up by Silicon Valley company
CloudRanger is an enterprise back-up and disaster recovery platform for AWS
Irish companies among worst FTSE 100 performers as Dublin closes for holiday
European shares extend recovery as dealmaking takes centre stage
What is Stem and why is it important?
Stem offers many career paths to graduates but what sets it apart from other areas of study?
Affordable homes lure buyers to the Royal County
New buyers are finding they get a lot more bang for their buck in this area
Uncertainty over Iran nuclear deal scares markets
Market report: Dealmaking dominates activity in UK stocks with gains for Shire and Virgin Money
Shire to recommend $64bn Takeda deal to shareholders
Acquisition would be largest ever outbound deal by Japanese company
Shire considers new offer from Takeda Pharmaceutical
Japanese drugmaker revises $60bn bid for biotechnology company
Allergan will not bid for Irish rare diseases specialist Shire
Reports had suggested pharma company would rival Takeda’s $60bn offer
Shire size not an obstacle to acquisition, Takeda CEO says
Shire still hasn’t received a formal approach or offer from Takeda
Brewing US-China trade war takes the fizz out of European stocks
C&C surges after purchase of Matthew Clark Bibendum, but UK investors play it safe
Shire may prove too big for Takeda to swallow
Doubts arise over how Japanese firm would pay for such deal given both groups’ debts
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices